Clinical Trial Results:
A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase II study on the efficacy and safety of Debio 025 combined with peg-IFNα2a and ribavirin in treatment naïve chronic hepatitis C genotype 1 patients
Summary
|
|
EudraCT number |
2008-004605-34 |
Trial protocol |
DE FR BE ES PL IT |
Global completion date |
06 Sep 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
07 Jul 2016
|
First version publication date |
25 Jun 2015
|
Other versions |
|
Summary report(s) |
Completed |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.